跳转至内容
Merck
CN

420174

顺-3-羟基-DL-脯氨酸

95%

别名:

(±)-顺式-3-羟基吡咯烷-2-羧酸

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C5H9NO3
化学文摘社编号:
分子量:
131.13
PubChem Substance ID:
UNSPSC Code:
12352200
Beilstein/REAXYS Number:
4130229
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

SMILES string

O[C@@H]1CCN[C@@H]1C(O)=O

InChI

1S/C5H9NO3/c7-3-1-2-6-4(3)5(8)9/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1

InChI key

BJBUEDPLEOHJGE-DMTCNVIQSA-N

assay

95%

reaction suitability

reaction type: solution phase peptide synthesis

application(s)

peptide synthesis

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Identification of 3-hydroxyproline residues in several proteins of Fasciola hepatica.
S E Bozas et al.
Experimental parasitology, 82(1), 69-72 (1996-01-01)
Mary Ann Weis et al.
The Journal of biological chemistry, 285(4), 2580-2590 (2009-11-27)
Collagen triple helices are stabilized by 4-hydroxyproline residues. No function is known for the much less common 3-hydroxyproline (3Hyp), although genetic defects inhibiting its formation cause recessive osteogenesis imperfecta. To help understand the pathogenesis, we used mass spectrometry to identify
Sanjay Morzaria et al.
The Journal of otolaryngology, 34(5), 297-303 (2005-09-27)
To develop an evidence-based algorithm for determining the etiology of bilateral sensorineural hearing loss (SNHL) in a child. The frequency of different etiologies was previously determined. A systematic review of the literature for articles published between 1940 and January 2003
Improved method for the evaluation of 3-hydroxyproline and 4-hydroxyproline in the urine.
G Bellon et al.
Journal of chromatography, 230(2), 420-426 (1982-07-09)
P Wiedemann
Fortschritte der Ophthalmologie : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 86(2), 115-120 (1989-01-01)
The steps in the formal pathogenesis of proliferative vitreoretinopathy (inflammation, proliferation, the synthesis of extracellular matrix, and contraction) provide the target points for medical treatment. A survey of the relevant drugs is given. Anti-inflammatory agents (steroids, heparin) and antiproliferative agents

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持